Author: Kim Doyil Akcakanat Argun Singh Gopal Sharma Chandeshwar Meric-Bernstam Funda
Publisher: Informa Healthcare
ISSN: 0897-7194
Source: Growth Factors, Vol.27, Iss.1, 2009-02, pp. : 12-21
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Ribosomal protein S6 kinase 1 (S6K1), a critical mediator of cell growth, is overexpressed in breast cancer and is associated with poor prognosis. S6K1 has two known isoforms, p85S6K1 and p70S6K1. p85S6K1 is characterized by 23 additional amino acids in the N-terminus of p70S6K1. This is thought to target p85S6K1 to the nucleus, while p70S6K1 is mainly cytoplasmic. We sought to determine the activation, regulation, and function of p70S6K1 and p85S6K1 in breast cancer. We found that most breast cancer cell lines expressed both isoforms. Mitogen-dependent pathways concordantly regulated phosphorylation on T389, S371, and T421/S424. Phosphorylation of both isoforms was inhibited by PI3K/mTOR inhibitors. Mitogen-dependent pathways concordantly regulated the phosphorylation of the two isoforms on T389, S371, and T421/S424. Both isoforms had S6 kinase activity. We also detected a p60 isoform with antibodies to the p70S6K1 C-terminal but not the N-terminal. Further studies on S6K1 isoforms are warranted for therapeutically targeting this pathway.
Related content
By Jastrzebski Katarzyna Hannan Katherine Tchoubrieva Elissaveta Hannan Ross Pearson Richard
Growth Factors, Vol. 25, Iss. 4, 2007-08 ,pp. :
By Qin Xue Zheng Xiaoxu Qi Hui Dou Dou Raj J. Gao Yuansheng
Pflügers Archiv, Vol. 454, Iss. 6, 2007-09 ,pp. :
Regulation of ENaC biogenesis by the stress response protein SERP1
By Faria Diana Lentze Nicolas Almaça Joana Luz Simão Alessio Luisa Tian Yuemin Martins José Cruz Pedro Schreiber Rainer Rezwan Mandana Farinha Carlos Auerbach Daniel Amaral Margarida Kunzelmann Karl
Pflügers Archiv, Vol. 463, Iss. 6, 2012-06 ,pp. :